Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

Web-survey predicts pregnancy chances via in vitro fertilization

July 21, 2008

T2 is eyeing revolutionary diagnostics in small package

July 18, 2008

LabCorp has promising results with an ovarian cancer assay

July 17, 2008

Web-based EHRs more affordable, easier to switch to over standard

July 16, 2008

Intel gets FDA green light for its care management tool

July 15, 2008

Registry gathering data on Sonablate for prostate cancer

July 11, 2008

LabCorp has promising results with an ovarian cancer assay

July 10, 2008

VCs, others say nonexistent IPO market worst in 30 years

July 10, 2008

Hemopure clinical trial could be final hope for struggling Biopure

July 9, 2008

VCs, others say nonexistent IPO market worst in 30 years

July 7, 2008

View All Articles by Omar Ford

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...